JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Biermer, M.
Right arrow Articles by Schneider, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Biermer, M.
Right arrow Articles by Schneider, R. J.

 Previous Article  |  Next Article 

Journal of Virology, April 2003, p. 4033-4042, Vol. 77, No. 7
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.7.4033-4042.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Tumor Necrosis Factor Alpha Inhibition of Hepatitis B Virus Replication Involves Disruption of Capsid Integrity through Activation of NF-{kappa}B

Michael Biermer,{dagger} Robyn Puro, and Robert J. Schneider*

Department of Microbiology, New York University School of Medicine, New York, New York 10016

Received 29 August 2002/ Accepted 20 December 2002

Chronic infection by hepatitis B virus results from an inability to clear the virus, which is associated with liver disease and liver cancer. Tumor necrosis factor alpha (TNF-{alpha}) is associated with noncytopathic clearance of hepatitis B virus in animal models. Here we demonstrate that the nuclear factor {kappa}B (NF-{kappa}B) signaling pathway is a central mediator of inhibition of hepatitis B virus by TNF-{alpha} and we describe the molecular mechanism. TNF-{alpha} is shown to suppress hepatitis B virus DNA replication without cell killing by disrupting the formation or stability of cytoplasmic viral capsids through a pathway requiring the NF-{kappa}B-activating inhibitor of {kappa}B kinase complex IKK-{alpha}/ß and active transcription factor NF-{kappa}B. Hepatitis B virus replication could also be inhibited and viral capsid formation could be disrupted in the absence of TNF-{alpha} solely by overexpression of IKK-{alpha}/ß or strong activation of NF-{kappa}B. In contrast, inhibition of NF-{kappa}B signaling stimulated viral replication, demonstrating that HBV replication is both positively and negatively regulated by the level of activity of the NF-{kappa}B pathway. Studies are presented that exclude the possibility that HBV inhibition by NF-{kappa}B is carried out by secondary production of gamma interferon or alpha/beta interferon. These results identify a novel mechanism for noncytopathic suppression of hepatitis B virus replication that is mediated by the NF-{kappa}B signaling pathway and activated by TNF-{alpha}.


* Corresponding author. Mailing address: Department of Microbiology, New York University School of Medicine, 550 First Ave., New York, NY 10016. Phone: (212) 263-6006. Fax: (212) 263-8276. E-mail: schner01{at}popmail.med.nyu.edu.

{dagger} Present address: Department of General Virology, Heinrich-Pette-Institut, Hamburg, Germany.


Journal of Virology, April 2003, p. 4033-4042, Vol. 77, No. 7
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.7.4033-4042.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.